VirtualCare2Go Review
Best for: Same-day compounded semaglutide (injection or oral tablet) with nationwide shipping
VirtualCare2Go is a US telehealth provider offering compounded GLP-1 weight-loss medication with same-day visits and national shipping. Compounded semaglutide starts at $279/month and oral semaglutide tablets at $599/month, with all-inclusive injection programs around $629/month. Care is fully online; a public state list is not enumerated on the site.
Medium confidence · Last verified 2026-06-05 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
VirtualCare2Go is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
VirtualCare2Go prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| From | compounded | $279 |
| Oral tablets | compounded | $599 |
✓ Pros
- •Compounded semaglutide from $279/month with same-day telehealth visits
- •Oral semaglutide tablet option available
- •Ships nationally direct to your door
✗ Cons
- •Compounded GLP-1s are not FDA-approved finished products
- •Pricing is on the higher side for compounded semaglutide
- •Public state list is not enumerated
- •Cash-pay only
Ready to start with VirtualCare2Go?
Starting at $279/month. See current pricing and start your free consultation.
Sources & methodology
Our VirtualCare2Go review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to VirtualCare2Go
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with VirtualCare2Go?
Starting at $279/month. See current pricing and start your free consultation.